| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |